vs
STANDARD BIOTOOLS INC.（LAB）与Eightco Holdings Inc.（ORBS）财务数据对比。点击上方公司名可切换其他公司
STANDARD BIOTOOLS INC.的季度营收约是Eightco Holdings Inc.的1.9倍（$19.6M vs $10.2M），STANDARD BIOTOOLS INC.净利率更高（-177.4% vs -2281.6%，领先2104.2%），STANDARD BIOTOOLS INC.同比增速更快（-11.5% vs -49.9%），Eightco Holdings Inc.自由现金流更多（$-11.0M vs $-23.1M），过去两年Eightco Holdings Inc.的营收复合增速更高（13.1% vs -12.2%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
LAB vs ORBS — 直观对比
营收规模更大
LAB
是对方的1.9倍
$10.2M
营收增速更快
LAB
高出38.4%
-49.9%
净利率更高
LAB
高出2104.2%
-2281.6%
自由现金流更多
ORBS
多$12.1M
$-23.1M
两年增速更快
ORBS
近两年复合增速
-12.2%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $10.2M |
| 净利润 | $-34.7M | $-232.5M |
| 毛利率 | 48.5% | -13.0% |
| 营业利润率 | -168.5% | -475.0% |
| 净利率 | -177.4% | -2281.6% |
| 营收同比 | -11.5% | -49.9% |
| 净利润同比 | -28.8% | -9183.3% |
| 每股收益（稀释后） | $-0.09 | $-2.34 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LABORBS
| Q4 25 | — | $10.2M | ||
| Q3 25 | $19.6M | $5.3M | ||
| Q2 25 | $21.8M | $7.6M | ||
| Q1 25 | $40.8M | $9.9M | ||
| Q4 24 | — | $20.3M | ||
| Q3 24 | $22.1M | $6.1M | ||
| Q2 24 | $22.5M | $5.3M | ||
| Q1 24 | $45.5M | $8.0M |
净利润LABORBS
| Q4 25 | — | $-232.5M | ||
| Q3 25 | $-34.7M | $-25.8M | ||
| Q2 25 | $-33.5M | $-1.2M | ||
| Q1 25 | $-26.0M | $-2.5M | ||
| Q4 24 | — | $-2.5M | ||
| Q3 24 | $-26.9M | $-3.2M | ||
| Q2 24 | $-45.7M | $4.4M | ||
| Q1 24 | $-32.2M | $1.9M |
毛利率LABORBS
| Q4 25 | — | -13.0% | ||
| Q3 25 | 48.5% | -3.7% | ||
| Q2 25 | 48.8% | 16.4% | ||
| Q1 25 | 48.4% | 8.2% | ||
| Q4 24 | — | 8.2% | ||
| Q3 24 | 54.9% | 26.5% | ||
| Q2 24 | 46.1% | 25.1% | ||
| Q1 24 | 53.1% | 17.5% |
营业利润率LABORBS
| Q4 25 | — | -475.0% | ||
| Q3 25 | -168.5% | -116.9% | ||
| Q2 25 | -118.1% | -15.9% | ||
| Q1 25 | -80.8% | -14.3% | ||
| Q4 24 | — | -11.9% | ||
| Q3 24 | -120.9% | -29.1% | ||
| Q2 24 | -134.5% | -16.4% | ||
| Q1 24 | -132.2% | -39.6% |
净利率LABORBS
| Q4 25 | — | -2281.6% | ||
| Q3 25 | -177.4% | -487.6% | ||
| Q2 25 | -153.7% | -15.4% | ||
| Q1 25 | -63.8% | -25.7% | ||
| Q4 24 | — | -12.3% | ||
| Q3 24 | -122.0% | -52.5% | ||
| Q2 24 | -203.3% | 84.2% | ||
| Q1 24 | -70.6% | 24.4% |
每股收益（稀释后）LABORBS
| Q4 25 | — | $-2.34 | ||
| Q3 25 | $-0.09 | $-0.58 | ||
| Q2 25 | $-0.09 | $-0.38 | ||
| Q1 25 | $-0.07 | $-0.84 | ||
| Q4 24 | — | $-1.44 | ||
| Q3 24 | $-0.07 | $-1.77 | ||
| Q2 24 | $-0.12 | $2.15 | ||
| Q1 24 | $-0.27 | $1.42 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $58.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $399.7M | $232.6M |
| 总资产 | $539.6M | $250.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资LABORBS
| Q4 25 | — | $58.5M | ||
| Q3 25 | $129.4M | $23.7M | ||
| Q2 25 | $158.6M | $696.3K | ||
| Q1 25 | $150.9M | $434.4K | ||
| Q4 24 | — | $239.2K | ||
| Q3 24 | $210.6M | $2.4M | ||
| Q2 24 | $269.8M | $363.1K | ||
| Q1 24 | $287.1M | $808.8K |
总债务LABORBS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $55.2M | — | ||
| Q2 24 | $55.1M | — | ||
| Q1 24 | $55.0M | — |
股东权益LABORBS
| Q4 25 | — | $232.6M | ||
| Q3 25 | $399.7M | $339.2M | ||
| Q2 25 | $424.5M | $8.9M | ||
| Q1 25 | $454.6M | $9.7M | ||
| Q4 24 | — | $11.9M | ||
| Q3 24 | $489.3M | $13.0M | ||
| Q2 24 | $510.3M | $13.8M | ||
| Q1 24 | $577.3M | $3.9M |
总资产LABORBS
| Q4 25 | — | $250.2M | ||
| Q3 25 | $539.6M | $355.5M | ||
| Q2 25 | $557.0M | $48.7M | ||
| Q1 25 | $579.6M | $47.6M | ||
| Q4 24 | — | $50.8M | ||
| Q3 24 | $681.5M | $49.2M | ||
| Q2 24 | $708.7M | $48.4M | ||
| Q1 24 | $777.7M | $50.2M |
负债/权益比LABORBS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | 0.10× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $-11.0M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $-11.0M |
| 自由现金流率自由现金流/营收 | -118.1% | -107.7% |
| 资本支出强度资本支出/营收 | 4.5% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-111.1M | — |
8季度趋势，按日历期对齐
经营现金流LABORBS
| Q4 25 | — | $-11.0M | ||
| Q3 25 | $-22.2M | $-1.6M | ||
| Q2 25 | $-20.7M | $-659.2K | ||
| Q1 25 | $-30.3M | $999.8K | ||
| Q4 24 | — | $-6.6M | ||
| Q3 24 | $-27.9M | $77.7K | ||
| Q2 24 | $-39.0M | $-440.3K | ||
| Q1 24 | $-62.5M | $-723.3K |
自由现金流LABORBS
| Q4 25 | — | $-11.0M | ||
| Q3 25 | $-23.1M | — | ||
| Q2 25 | $-22.6M | $-661.3K | ||
| Q1 25 | $-35.3M | $999.7K | ||
| Q4 24 | — | $-6.6M | ||
| Q3 24 | $-30.1M | $73.0K | ||
| Q2 24 | $-41.0M | — | ||
| Q1 24 | $-63.3M | — |
自由现金流率LABORBS
| Q4 25 | — | -107.7% | ||
| Q3 25 | -118.1% | — | ||
| Q2 25 | -103.6% | -8.7% | ||
| Q1 25 | -86.6% | 10.1% | ||
| Q4 24 | — | -32.7% | ||
| Q3 24 | -136.4% | 1.2% | ||
| Q2 24 | -182.2% | — | ||
| Q1 24 | -138.9% | — |
资本支出强度LABORBS
| Q4 25 | — | 0.0% | ||
| Q3 25 | 4.5% | 0.0% | ||
| Q2 25 | 8.7% | 0.0% | ||
| Q1 25 | 12.4% | 0.0% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | 10.2% | 0.1% | ||
| Q2 24 | 8.6% | — | ||
| Q1 24 | 1.7% | — |
现金转化率LABORBS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -0.10× | ||
| Q1 24 | — | -0.37× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
ORBS
暂无分部数据
